target

SYNTHORX

bidder

Sanofi

£1,902m

50 dealmakers

target

Pvp Biologics

bidder

Takeda Pharmaceutical Company

£255m

12 dealmakers

target

Tetra Therapeutics

bidder

SHIONOGI

£410m

23 dealmakers

target

ARCHERDX

bidder

INVITAE

£1,127m

56 dealmakers

target

Resolution Bioscience

bidder

Agilent Technologies

£394m

31 dealmakers

target

Rodeo Therapeutics Corporation

bidder

Amgen

£525m

18 dealmakers

target

Lengo Therapeutics

bidder

Blueprint Medicines

£348m

57 dealmakers

target

Personal Genome Diagnostics

bidder

LABCORP

£425m

18 dealmakers

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

target

Hbt Labs

bidder

American Regent

value n/a

27 dealmakers

target

Metacrine

bidder

EQUILLIUM

£28m

13 dealmakers

target

Good Therapeutics

bidder

Roche Holdings

£216m

21 dealmakers

target

Famy Life Sciences

bidder

VIATRIS

£659m

58 dealmakers

target

Neogene Therapeutics

bidder

Astrazeneca

£264m

60 dealmakers

target

Purigen Biosystems

bidder

Bionano Genomics

£52m

35 dealmakers

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

target

Travere Therapeutics (bile Acid Product Portfolio)

bidder

Mirum Pharmaceuticals

£366m

32 dealmakers

target

Tentarix Biotherapeutics

bidder

Gilead Sciences

£52m

13 dealmakers

target

Carmot Therapeutics

bidder

Roche Holdings

£2,438m

49 dealmakers

target

Patch Biosciences

bidder

Ginkgo Bioworks

value n/a

25 dealmakers